AseBio presents the "Map of Capabilities against Antibiotic Resistance" of the Spanish bio... 21/11/2023 Healthcare Antibiotic resistance The map reveals that 43 AseBio partners are taking direct actions aimed at combating antibiotic resistance through... AseBio
AseBio presents the "Map of Capabilities against Antibiotic Resistance" of the Spanish bio... 21/11/2023 The biotech sector provides cross-cutting solutions ranging from the diagnosis, research, and treatment of infectious... AseBio
BCN HEALTH has presented several communications at the EASL and AASLD congresses evaluatin... 20/11/2023 Healthcare Access to innovation BCN HEALTH has participated in the EASL and AASLD congresses with several communications that have reported on the... Partners - BCN Health
GENESIS Biomed consolidates its growth in the biomedical sector 17/11/2023 Healthcare The consultancy firm GENESIS Biomed, a national reference in advisory services for early-stage projects in the... Partners - Parc Científic de Barcelona
Peaches Biotech receives the Innova Health 2023 Award for the most innovative project 15/11/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies It is a recognition of the company, its professionals and the advances achieved in its secretome-based therapies Partners - PEACHES BIOTECH S.L.
Science and Innovation, the Pending Subject of Spain and a Weak Point in the Progress towa... 10/11/2023 Healthcare Access to innovation Climate change Agrifood Industrial biotechnology Financing Talento Spain needs a clear regulatory framework and support for the biotechnological industry with long-term investments... AseBio
Science and Innovation, the Pending Subject of Spain and a Weak Point in the Progress towa... 10/11/2023 Beyond the direct impact of biotechnology on human health and the planet, investment in science and biotechnology has a... AseBio
Kynexis Launched to Advance Precision Therapeutics for Brain Diseases 07/11/2023 Healthcare Access to innovation Lead candidate KYN-5356, a first-in-class small Molecule KAT-II inhibitor advancing toward the clinic for cognitive... Partners - Ysios Capital Partners
ORYZON announces Last Patient Last Visit in its Phase IIb PORTICO study for Borderline Per... 07/11/2023 Healthcare Access to innovation Innovative drugs Multiple primary endpoints include reduction in agitation and aggression and overall BPD disease improvement. Partners - Oryzon Genomics
BIO360 Nantes, France Del 24/01/2024 to 25/01/2024 Healthcare Bioeconomy Bio360 Expo and the Biotransition: Paving the Path to a Sustainable Future
